Hong Kong medical device registration timeline
Source-linked clocksMedical Device Division (MDD) review clocks and end-to-end planning ranges, using the 4-class (I, II, III, IV) classification system.
| Class / pathway | Review clock | Planning total | With prior approval | Provenance |
|---|---|---|---|---|
| Class II(MDACS listing (Form MD101 via MDIS)) GN-02 clause 5.3.1: vetting and approval should normally be completed within 12 weeks, counted from submission of the application and all required supporting information — including anything requested mid-assessment, so a question resets the practical start | 12 weeks | 3-4 months | — | Verified |
| Class III(MDACS listing (Form MD101 via MDIS)) Same 12-week GN-02 clause 5.3.1 clock as Class II and Class IV — MDD does not band the listing period by risk class | 12 weeks | 3-5 months | — | Verified |
| Class IV(MDACS listing (Form MD101 via MDIS)) Same 12-week GN-02 clause 5.3.1 clock; Class IV was the first class MDACS opened to listing when the system was phased in from 2004 | 12 weeks | 3-6 months | — | Verified |
Review clocks exclude applicant hold time · planning totals are estimatesHong Kong Medical Device Registration Process
Step-by-step MDD registration process. Total estimated timeline: 3-4 months.
Step 1: Pre-Submission Preparation
1-3 monthsGather technical documentation, quality management system (QMS) records, and clinical data required by MDD. Appoint a Local Responsible Person (LRP).
Step 2: Application Submission
1-2 weeksSubmit complete registration dossier to MDD including device description, risk analysis, and testing reports.
Step 3: Administrative Review
2-4 weeksMDD reviews application for completeness. May request additional documents or clarifications.
Step 4: Technical Evaluation
12 weeksIn-depth technical assessment of device safety and performance. MDD may issue questions.
Step 5: Registration Approval
1-2 weeksUpon successful review, MDD issues Hong Kong market authorization certificate.
Prioritised processing for first-of-its-kind devices, devices approved through another regulator’s innovation channel (NMPA 創新器械名錄, FDA De Novo) within 5 years, devices with AI features approved within 5 years, or devices whose core technology was patented within 5 years
Eligibility: At least one of the four E001 innovation criteria, Conformity Assessment Certificate or reference marketing approval still required
Streamlined review, applied by default unless the applicant opts out
Eligibility: Applicant is an LRP with a valid LRP listing number, No reported deaths or serious injury associated with the device, locally or worldwide, No active recalls, field safety corrective actions or adverse events, locally or worldwide, Every device in the application is supported by two or more valid, independent marketing approvals from the D002 jurisdictions
- Local Responsible Person incorporated or business-registered in Hong Kong, either the manufacturer or backed by a designation letter from it
- Class I general medical devices and Class A IVDs cannot be listed at all — GN-01 clause 4.2.1 confines listing to Class II/III/IV devices and Class B/C/D IVDs, so there is no clock to publish for the lowest class and its absence is not a data gap
- Chinese/English labelling per TR-005
- QMS evidence: ISO 13485 from a GACI-signatory-accredited body, GB/T 42061, an NMPA manufacturing licence, MDSAP, or KGMP — each with its own paired marketing-approval requirement
- Either an MDACS Conformity Assessment Certificate (D001) or reference-market marketing approvals (D002)
- Essential Principles Conformity Checklist MD-CCL, or an EU ER/GSPR checklist where EU approvals are submitted, with supporting evidence due within 2 weeks of a request
- MDACS is an administrative, voluntary system pending statutory control; listing is nonetheless required for supply into public healthcare institutions
MDSAP: Accepted as QMS evidence when paired with a marketing approval from a jurisdiction that recognises MDSAP
Reviewed 2026-08-30. End-to-end totals remain planning estimates.